Infliximab does not increase colonic cancer risk associated to murine chronic colitis

AIM: To explore the influence of Infliximab (IFX) on cancer progression in a murine model of colonic cancer associated to chronic colitis. METHODS: AOM/DSS model was induced in C57BL/6 mice. Mice were injected with IFX (5 mg/kg) during each DSS cycle while control mice received saline. Body weight,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Gastroenterol
Main Authors: Lopetuso, Loris R, Petito, Valentina, Zinicola, Tiziano, Graziani, Cristina, Gerardi, Viviana, Arena, Vincenzo, Caristo, Maria Emiliana, Poscia, Andrea, Cammarota, Giovanni, Papa, Alfredo, Cufino, Valerio, Sgambato, Alessandro, Gasbarrini, Antonio, Scaldaferri, Franco
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2016
Teme:
Basic Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124977/
https://ncbi.nlm.nih.gov/pubmed/27956796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i44.9727
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki